Biopsy Device Market Demand, Features, Top Players, Key Statistics, Forecast - 2026 | FMI Report

1
Biopsy Device Market Business overview,
Upcoming Trends, Growth, Analysis Segmentation,
Outlookand Forecast 2026 FMI

• March 2021

Report Id REP-GB-1192Published On
2017-01-10Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Biopsy Device Market Analysis
Key Players Focussing on Strategic MA for
Amplified Market Shares  Patients are
increasingly preferring minimally invasive
surgical procedures in order to avoid
conventional surgical complications and
side-effects, promoting sales of biopsy devices,
leading to the growth of the biopsy devices
globally. In addition to enabling the accurate
diagnosis, a biopsy device assures minimal
patient discomfort and trauma. This is identified
to be a major factor impacting the popularity of
biopsy, and biopsy device thereby. Over the
10-year forecast period 2016-2026, the global
biopsy device market is estimated to witness a
moderate yet promising CAGR of 6.5, according to
Future Market Insights. In a recently published
report titled "Biopsy Device Market Global
Industry Analysis and Opportunity Assessment,
2016-2026", Future Market Insights analyses the
market for biopsy device and offers key insights
into the market condition for the aforementioned
period. Valued at around US 1,397 Mn in 2016,
the market will possibly attain the revenues
beyond US 2,621 Mn by 2026-end. Request a
Sample Report with Table of Contents http//www.f
uturemarketinsights.com/reports/sample/rep-gb-1192
5
Lung Cancer Surgery Market Analysis

• Key Opportunities for Manufacturers and
  Suppliers, Grasped by Future Market Insights
  Research 
• Developing economies present lucrative, untapped
  markets for biopsy device.
• Growing adoption of hybrid imaging technology
  will underpin new growth opportunities.
• Following massive consumption by hospitals,
  demand for biopsy device from specific oncology
  centres and research institutes will prompt at
  multiple opportunities in near future.
• Surging demand for minimal invasive breast biopsy
  highlight lucrative opportunities that lie in the
  breast cancer sector.
• Increasing adoption of biopsy device by
  oncologists will generate several revenue
  generation opportunities in the disease
  monitoring sector.

Ask an Analyst _at_ https//www.futuremarketinsights.
com/ask-question/rep-gb-1192
6
Lung Cancer Surgery Market Analysis
Supported by increasing discretionary funding for
cancer research, growing government expenditure
for healthcare and favourable reimbursement
scenario (especially in the U.S.) will
collectively elevate the revenue sales of the
global biopsy device market. Collaborations
between various government and private companies,
fuelled by increasing awareness about disease
diagnosis and monitoring, will further elevate
the market growth in near future. MA and
Technological Upgrades Remain at the
Forefront  A majority of key players in the
global biopsy device market are currently
focusing on providing innovative biopsy tests and
technological upgrades. Mergers, acquisitions,
and partnerships with diagnostic laboratories
will help to strengthen their presence in the
global market.
7
Lung Cancer Surgery Market Analysis
Among the top companies, Becton, Dickinson and
Company is concentrating on innovative,
cost-effective product development, whereas
Hologic, Inc. is targeting manufacture and sales
of biopsy devices, especially for breast cancer
surgeries. Other notable players include Boston
Scientific Inc., C. R. Bard, Inc., B. Braun
Melsungen AG, Cook Medical, INRAD Inc., and
PLANMED OY. Argon Medical, one of the promising
new entrants, is expanding its product portfolio
and collaborating with established players,
whereas for Devicor Medical Products Inc., MA
remains the key strategy.
Preview Analysis on Global Biopsy Device Market
Segmentation By Product Type - Guidance System
(Stereotactic X-Ray Guided Biopsy, Ultrasound
Guided Biopsy, MRI Guided Biopsy), Needles (Core
Needles, Fine Aspiration Needles), Guns and
Others (Brushes, Curettes and Punches Etc.) By
Application - Medical Diagnosis and Scientific
Research By End Use - Hospital, Specialised
Oncology Centres, Diagnostic Centres and Research
Institutes http//www.futuremarketinsights.com/re
ports/biopsy-device-market
8
Lung Cancer Surgery Market Analysis
North America Retains the Most Lucrative Market,
Developing Countries to Witness Impressive Growth
over 2016-2026  North America will remain the
dominant market, reaching nearly US 882 Mn by
2026 end, accounting for over 33 share of the
market. Western Europe is expected to remain the
second largest market for biopsy device, crossing
a value of US 683 Mn by the end of 2026,
capturing over 26 share of the market. APEJ,
with around 14 market value share in 2026, is
likely to reach US 370.0 Mn by the end of
forecast period. MEA will register the fastest
CAGR of 7.3, followed by APEJ and Latin
America with the respective CAGRs of 7.1 and
6.5 over 2016-2026. North America, Europe,
and Japan will see moderate growth over the
forecast period. Needles Continue to Drive
Product Type Segment By product type, needles
will remain dominant with over 36 share of the
market value in 2026, whereas guns will represent
the second largest sub-segment with over 26
market value share in 2026. With growing
significance of early diagnosis of breast biopsy,
guidance system segment is estimated to gain
around 222 BPS in its market share by 2026 over
2016.
9
Lung Cancer Surgery Market Analysis
Stereostatic X-ray guided biopsy will drive the
guidance system segment through to 2026. Reagents
and kits will witness moderate consumption. Medic
al Diagnostics Monopolise Application
Segment  Based on application type, medical
diagnostics will continue to hold a dominant
share of over 61 by 2026 end, in terms of
revenues. Scientific research, accounting for the
rest, will witness an impressively growing CAGR
of 6.9 over 2016-2026. This segment is expected
to reach beyond US 1,008.0 Mn in
2026. Hospitals Remain Largest End-use
Consumer  By end-user, hospitals will continue
to contribute nearly 50 share to the market
value by 2026 end. This end-use segment will
witness a robust CAGR of 8.2. Diagnostic centres
will account for over 23 in 2026 with a slight
decline over 2016-2026, whereas specialised
oncology centres are anticipated to expand at a
CAGR of 6.1 during 2016-2026. Buy Report Now _at_
https//www.futuremarketinsights.com/checkout/1192

10
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)